TB-500 Fragment
Thymosin β4 C-terminal fragment (Ac-SDKP) for actin-binding dynamics and endothelial cell migration assays.
$100 minimum order. Free shipping over $300, otherwise $20. US domestic only. Zelle orders get an extra 5% off at checkout.
About this compound
The Ac-SDKP tetrapeptide is the biologically active C-terminal fragment of Thymosin Beta-4. It binds G-actin and regulates actin polymerization dynamics. In cell culture, it promotes endothelial cell migration and tubulogenesis through α4β1 integrin interactions. Cytoskeletal dynamics studies, endothelial migration assays, cardiac fibrosis research models, and angiogenesis experiments.
| CAS | 77591-33-4 |
|---|---|
| Purity | ≥99% (HPLC verified) |
| Storage | −20°C, protect from light |
| Fill | 12mg per vial |
| Form | Lyophilized powder |
| Lab results | 6 on file · latest Nov 2025 |
Certificates of analysis
Results come from Janoshik Analytical Laboratory, an independent lab. Open any result to see the full report, or look up the test ID at janoshik.com.
| Date | Test | Batch | Test ID | Link |
|---|---|---|---|---|
| Mar 2026 | TB-500 20mgHPLC identity & purity · Janoshik Analytical Laboratory | – | #111318 | View result |
| Nov 2025 | TB-500 Fragment 12mgHPLC identity & purity · Janoshik Analytical Laboratory | Batch 5 | #85618 | View result |
| Aug 2025 | TB-500 Fragment 12mgHPLC identity & purity · Janoshik Analytical Laboratory | #1 | #73231 | View result |
| Aug 2025 | TB-500 Fragment 12mgHPLC identity & purity · Janoshik Analytical Laboratory | #2 | #72921 | View result |
| Prior | TB-500 Fragment 12mgHPLC identity & purity · Janoshik Analytical Laboratory | Batch 5 | #50505 | View result |
| Prior | TB-500 (Fragment) 10mgHPLC identity & purity · Janoshik Analytical Laboratory | – | #41965 | View result |
Results are from our supplier's published testing records. Dates show when each result was published. Each test covers the sample sent to the lab. See every compound on the lab results page.
More research compounds
BPC-157
Pentadecapeptide studied for cytoprotective signaling, VEGF/EGF modulation, and extracellular matrix interactions.
BPC-157 + TB-500 Mix
Co-lyophilized BPC-157 (15mg) and TB-500 Fragment (15mg) in a single vial for concurrent pathway research.
Semaglutide
Long-acting GLP-1 receptor agonist analog for pancreatic β-cell signaling and incretin axis research.
Tirzepatide 10mg
Dual GIP/GLP-1 receptor co-agonist for comparative receptor selectivity and metabolic pathway research.
For in vitro research use only. Not for human or veterinary use. Not a drug, food, or cosmetic. By ordering you agree to our terms of service and research use agreement.